Swertiamarin 20mg
Swertiamarin has shown potential as antiatherogenic agent by inhibiting HMG-CoA reductase activity in high cholesterol fed rats.
| Trivial name | Swertiamarin 20mg |
| Catalog Number | A12128-20 |
| Alternative Name(s) | (4ar-(4a-alpha,5-beta,6-alpha))-ranosyloxy)-4a-hydroxy |
| Molecular Formula | C16H22O10 |
| CAS# | 17388-39-5 |
| SMILES | C=C[C@H]1[C@@H](OC=C2[C@]1(CCOC2=O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O |
| Size | 20mg |
| Supplier Page | http://www.adooq.com/swertiamarin.html |